Clinical-Use-Associated Decrease in Susceptibility of Vancomycin-Resistant Enterococcus faecium to Linezolid: a Comparison with Quinupristin-Dalfopristin.

导出原文传递

翻译打印收藏纠错

作者： Raad II ^[1] ; Hanna HA ; Hachem RY ; Dvorak T ; Arbuckle RB ; Chaiban G ; Rice LB

作者单位： The University of Texas M. D. Anderson Cancer Center, Department of Infectious Diseases, Infection Control and Employee Health (Unit 402), 1515 Holcombe Blvd., Houston, TX 77030. iraad@mdanderson.org ^[1]

关键词 Clinical linezolid Enterococcus faecium Decrease quinupristin-dalfopristin 肠球菌屎

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Antimicrobial Agents and Chemotherapy

2004年48卷9期

3583-3585页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Clinical-Use-Associated Decrease in Susceptibility of Vancomycin-Resistant Enterococcus faecium to Linezolid: a Comparison with Quinupristin-Dalfopristin.

Antimicrobial Agents and Chemotherapy

相似文献

Antimicrobial Agents and Chemotherapy

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Clinical-Use-Associated Decrease in Susceptibility of Vancomycin-Resistant Enterococcus faecium to Linezolid: a Comparison with Quinupristin-Dalfopristin.

Antimicrobial Agents and Chemotherapy

相似文献

Antimicrobial Agents and Chemotherapy

相关期刊

检索历史清除